← Leaderboards
Siyuan Ding
Stanford University
$6,676,482
Attributed
$8,826,169
Total exposure
11
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.6M · FY2018–25$5M$3.8M$2.5M$1.3M$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$8,826,169 · 11
By mechanism
R01$6,609,026 · 5
R21$1,282,875 · 3
R00$498,000 · 1
R56$304,049 · 1
K99$132,219 · 1
Top collaborators
- Matthew Aaron Ciorba5 shared
- James Michael Fleckenstein2 shared
- Purnima Dubey1 shared
- Jianrong Li1 shared
Most similar at Stanford University
Same institution · by research overlap
- Paul Joseph Utz$20,350,048
- Shan X. Wang$16,205,138
- Xing Wang$2,667,782
- Harry Bernard Greenberg$91,083,131
Others in their field
Other Emerging Leaders on “Intestines”
- George Robert Painter · University Of Alabama At Birmingham$27,619,145
- Gary Fanger · Rise Therapeutics, Llc$20,487,485
- Chun-Jun Guo · Weill Medical Coll Of Cornell Univ$9,142,313
- Jakob H. Von Moltke · University Of Washington$8,392,078
- James W Janetka · Washington University$6,973,678
- Edward Burgard · Dignify Therapeutics, Llc$6,862,973
Research focus
IntestinesDiarrheaOrganoidsIntestinal EpitheliumVirusEpithelial CellsInfectionEnteralCellsSmall IntestinesMolecularCessation Of LifeRotavirusChildReverse GeneticsMortalityRotavirus InfectionsInfantGastroenteritisIn VivoIntegration Host FactorsMucous MembraneVaccine CandidateRotavirus Vaccines
Grant awards (23)
Development of novel multivalent mucosal vaccines for human noroviruses$798,173
R01 · FY2025 · AI
Mechanisms of VP4 Promoting Rotavirus Cell-to-Cell Transmission and Viral Pathogenesis$668,488
R01 · FY2025 · AI · contact PI
Mechanistic Investigation of a Rotavirus Auxiliary Protein NSP6 Countering Host Defense$593,021
R01 · FY2025 · AI · contact PI
Mechanisms of Gastrointestinal COVID-19$588,062
R01 · FY2025 · AI
Mechanisms of Gastrointestinal COVID-19$625,575
R01 · FY2024 · AI
Interferon-Stimulated Gene Inhibition of Rotavirus Replication and Viral Antagonism$393,750
R01 · FY2024 · AI · contact PI
Mechanism of Rotavirus Entry$194,375
R21 · FY2024 · AI · contact PI
Development of rotavirus-based enterotoxigenic Escherichia coli dual vaccines$155,500
R21 · FY2024 · AI · contact PI
Rotavirus interaction with gut intraepithelial lymphocytes$155,500
R21 · FY2024 · AI · contact PI
Mechanisms of Gastrointestinal COVID-19$705,849
R01 · FY2023 · AI
Interferon-Stimulated Gene Inhibition of Rotavirus Replication and Viral Antagonism$393,750
R01 · FY2023 · AI · contact PI
Rotavirus interaction with gut intraepithelial lymphocytes$272,125
R21 · FY2023 · AI · contact PI
Development of rotavirus-based enterotoxigenic Escherichia coli dual vaccines$272,125
R21 · FY2023 · AI · contact PI
Mechanism of Rotavirus Entry$233,250
R21 · FY2023 · AI · contact PI
Interferon-Stimulated Gene Inhibition of Rotavirus Replication and Viral Antagonism$77,750
R01 · FY2023 · AI · contact PI
Mechanisms of Gastrointestinal COVID-19$583,983
R01 · FY2022 · AI
Interferon-Stimulated Gene Inhibition of Rotavirus Replication and Viral Antagonism$393,750
R01 · FY2022 · AI · contact PI
Mechanisms of Gastrointestinal COVID-19$304,049
R56 · FY2022 · AI
Interferon-Stimulated Gene Inhibition of Rotavirus Replication and Viral Antagonism$393,750
R01 · FY2021 · AI · contact PI
Genetic and Biochemical Interrogation of Rotavirus-Cohesin Interaction$249,000
R00 · FY2021 · AI · contact PI
Interferon-Stimulated Gene Inhibition of Rotavirus Replication and Viral Antagonism$393,125
R01 · FY2020 · AI · contact PI
Genetic and Biochemical Interrogation of Rotavirus-Cohesin Interaction$249,000
R00 · FY2020 · AI · contact PI
Genetic and Biochemical Interrogation of Rotavirus-Cohesin Interaction$132,219
K99 · FY2018 · AI · contact PI